CD8A and neoplasm: Furthermore, a recent investigation on CRC has revealed that the TIME specifically endowed TAMs with elevated inhibitor of differentiation 1 expression, which interacted with STAT1 to suppress the chemoattractant CCL4, thereby excluding CD8+ T cells from tumor parenchyma [223].